EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bilirubin reductase regulates macrophage senescence and modulates implant-associated Staphylococcus aureus osteomyelitis

Jinye Zhang, Xinyuan Mao, Haonan Zheng, Kaifan Yang, Bin Yu

Chinese Journal of Traumatology · 2026-05

DOI: 10.1016/j.cjtee.2026.03.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chinese Journal of Traumatology, 2026-05. Verfasst von Jinye Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China; Division of Orthopaedics and Traumatology, Department o…. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Osteomyelitis (OM) remains difficult to diagnose early due to its heterogeneous pathology and reliance on invasive biopsy. This study aimed to identify reliable diagnostic biomarkers and explore their roles in macrophage senescence during OM pathogenesis. METHODS: We integrated single-cell RNA sequencing, bulk transcriptomics, and senescence-related gene sets to identify key genes. A diagnostic model was constructed using 3 machine-learning algorithms. Mendelian randomization analysis was applied to infer causality. Biliverdin Reductase A (BLVRA)'s role in macrophage senescence was validated through in vitro and in vivo Staphylococcus aureus infection models. RESULTS: Seven diagnostic biomarkers were identified, with a combined model showing high accuracy (area under the curve? > 0.96). Mendelian randomization analysis confirmed a causal effect of BLVRA on OM risk. Single-cell data revealed predominant BLVRA expression in macrophages. Experimental validation showed that Staphylococcus aureus infection upregulates BLVRA and promotes macrophage senescence. CONCLUSION: BLVRA is a causal mediator of OM linked to macrophage senescence. This multi-omics approach offers a basis for early diagnosis and suggests potential immunotherapeutic targets for OM.

Schlagwörter

Stichwörter der Autor:innen

BiomarkerMacrophageMendelian randomizationOsteomyelitisSenescenceSingle-cell transcriptome

Autor:innen und Institutionen

  • The First School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China; Division of Orthopaedics and Traumatology, Department of Orthopedics, Nanfang Hospital, Southern Medical University, Guangzho…
  • Division of Orthopaedics and Traumatology, Department of Orthopedics, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
  • Joint Surgery Department, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510000, China; Guangzhou Orthopedic Institute, Guangzhou Medical University, Guangzhou, 510000, China. Electronic addre…
  • Division of Orthopaedics and Traumatology, Department of Orthopedics, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China; Guangdong Provincial Key Laboratory of Bone and Cartilage Regenerative Medic…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, J., Mao, X., Zheng, H., Yang, K., & Yu, B. (2026). Bilirubin reductase regulates macrophage senescence and modulates implant-associated Staphylococcus aureus osteomyelitis. Chinese Journal of Traumatology. https://doi.org/10.1016/j.cjtee.2026.03.004

Vancouver

Zhang J, Mao X, Zheng H, Yang K, Yu B. Bilirubin reductase regulates macrophage senescence and modulates implant-associated Staphylococcus aureus osteomyelitis. Chinese Journal of Traumatology. 2026. doi:10.1016/j.cjtee.2026.03.004

BibTeX
@article{Zhang2026,
  author = {Zhang, Jinye and Mao, Xinyuan and Zheng, Haonan and Yang, Kaifan and Yu, Bin},
  title = {Bilirubin reductase regulates macrophage senescence and modulates implant-associated Staphylococcus aureus osteomyelitis},
  journal = {Chinese Journal of Traumatology},
  year = {2026},
  doi = {10.1016/j.cjtee.2026.03.004}
}
Kostenlos starten →